Pediatric brain cancer is rare. A doctor explains why some kids are more vulnerable than others

by Wendy RudermanCredit: Unsplash/CC0 Public DomainThe odds that a doctor will diagnose your child with pediatric cancer are slim, and the chances of a brain cancer diagnosis are even smaller.Each yea

Updated on: January 11,2024

Pediatric brain cancer is rare. A doctor explains why some kids are more vulnerable than others

by Wendy RudermanCredit: Unsplash/CC0 Public DomainThe odds that a doctor will diagnose your child with pediatric cancer are slim, and the chances of a brain cancer diagnosis are even smaller.Each yea

Updated on:January 11,2024

New insight into protein could pave the way for new cancer treatments

FEBRUARY 29, 2024by Anna Björklund, Identification of a conformational switch in c-MYC.aOverview of the MD strategy employed to identify regions that exhibit probe-induced conformational changes

Updated on: March 15,2024

New insight into protein could pave the way for new cancer treatments

FEBRUARY 29, 2024by Anna Björklund, Identification of a conformational switch in c-MYC.aOverview of the MD strategy employed to identify regions that exhibit probe-induced conformational changes

Updated on:March 15,2024

Does diabetes mean worse outcomes for cancer patients?

by Ryan O'Hare,Imperial College LondonCredit: Pixabay/CC0 Public DomainDiabetes is a known risk factor for developing cancer, but could it also predict how cancer patients respond to treatme

Updated on: January 07,2024

Does diabetes mean worse outcomes for cancer patients?

by Ryan O'Hare,Imperial College LondonCredit: Pixabay/CC0 Public DomainDiabetes is a known risk factor for developing cancer, but could it also predict how cancer patients respond to treatme

Updated on:January 07,2024

Researchers develop 'Goldilocks drug' to treat triple-negative breast cancer

by Mikayla Mace Kelley,University of ArizonacSNX1.3 competitively inhibits binding of EGFR to SNX1.ARibbon drawing of EGFR kinase domain (PDB ID 5CNO) and SNX1 Bar domain (PDB ID 4FZ

Updated on: February 20,2024

Researchers develop 'Goldilocks drug' to treat triple-negative breast cancer

by Mikayla Mace Kelley,University of ArizonacSNX1.3 competitively inhibits binding of EGFR to SNX1.ARibbon drawing of EGFR kinase domain (PDB ID 5CNO) and SNX1 Bar domain (PDB ID 4FZ

Updated on:February 20,2024

Proof-of-principle study shows immunity from routine vaccines has potential to fight cancer

by University of Massachusetts AmherstBacterial delivery of ovalbumin induces a specific CD8 T cell response. Credit:Frontiers in Immunology(2023). DOI: 10.3389/fimmu.2023.1228532A Un

Updated on: May 05,2024

Proof-of-principle study shows immunity from routine vaccines has potential to fight cancer

by University of Massachusetts AmherstBacterial delivery of ovalbumin induces a specific CD8 T cell response. Credit:Frontiers in Immunology(2023). DOI: 10.3389/fimmu.2023.1228532A Un

Updated on:May 05,2024

Novel biomarker for immune checkpoint inhibitors identified in human lethal cancers

by Liu Jia,Chinese Academy of SciencesA model depicting how the SETD2 inactivation sensitizes cancer cells to immune checkpoint blockade through the NR2F1-STAT1 pathway. Credit: Prof. Wang Yuexi

Updated on: January 26,2024

Novel biomarker for immune checkpoint inhibitors identified in human lethal cancers

by Liu Jia,Chinese Academy of SciencesA model depicting how the SETD2 inactivation sensitizes cancer cells to immune checkpoint blockade through the NR2F1-STAT1 pathway. Credit: Prof. Wang Yuexi

Updated on:January 26,2024

How do we know health screening programs work?

by Christian Yates,The ConversationLead-time bias can appear to make a treatment more effective than it actually is, if the perceived post-diagnosis survival time increases while the course of d

Updated on: January 10,2024

How do we know health screening programs work?

by Christian Yates,The ConversationLead-time bias can appear to make a treatment more effective than it actually is, if the perceived post-diagnosis survival time increases while the course of d

Updated on:January 10,2024

Research suggests natural compound could be promising new alternative treatment for colon cancer

FEBRUARY 26, 2024byUniversity of PortsmouthSchisandrin B inhibits the proliferation of human colon cancer cells. Credit:ACS Pharmacology & Translational Science(2024). DOI: 10.10

Updated on: March 27,2024

Research suggests natural compound could be promising new alternative treatment for colon cancer

FEBRUARY 26, 2024byUniversity of PortsmouthSchisandrin B inhibits the proliferation of human colon cancer cells. Credit:ACS Pharmacology & Translational Science(2024). DOI: 10.10

Updated on:March 27,2024

Enhanced melanoma vaccine offers improved survival for men

by University of VirginiaMel44 clinical trial design and long-term outcomes analysis. The Mel44 clinical trial was designed to evaluate immunologic and clinical outcomes after vaccination with ei

Updated on: March 30,2024

Enhanced melanoma vaccine offers improved survival for men

by University of VirginiaMel44 clinical trial design and long-term outcomes analysis. The Mel44 clinical trial was designed to evaluate immunologic and clinical outcomes after vaccination with ei

Updated on:March 30,2024

Study finds specific microbiome tied to long-term survival of patients with pancreatic cancer

by University of Texas M. D. Anderson Cancer CenterFlorencia McAllister, M.D. Credit: MD Anderson Cancer CenterA key difference between the few pancreatic cancer patients who survive long-term an

Updated on: July 04,2024

Study finds specific microbiome tied to long-term survival of patients with pancreatic cancer

by University of Texas M. D. Anderson Cancer CenterFlorencia McAllister, M.D. Credit: MD Anderson Cancer CenterA key difference between the few pancreatic cancer patients who survive long-term an

Updated on:July 04,2024

Exploring how gene mutations in tumors impact radiation sensitivity

byNorthwestern UniversityHigh-content irradiation platform reproducibility for the duration of the profiling effort. The signal-to-noise ratio (SNR), in blue represents the in-plate ratio of rad

Updated on: January 07,2024

Exploring how gene mutations in tumors impact radiation sensitivity

byNorthwestern UniversityHigh-content irradiation platform reproducibility for the duration of the profiling effort. The signal-to-noise ratio (SNR), in blue represents the in-plate ratio of rad

Updated on:January 07,2024

BCMA+ EV levels correlate with myeloma response to belantamab-mafodotin

by Impact Journals LLCPatient examples of inverse correlation of BCMA and FLC changes during course of therapy. Credit: 2023 Springer et al.A new research paper was published inOncotarget, entit

Updated on: January 26,2024

BCMA+ EV levels correlate with myeloma response to belantamab-mafodotin

by Impact Journals LLCPatient examples of inverse correlation of BCMA and FLC changes during course of therapy. Credit: 2023 Springer et al.A new research paper was published inOncotarget, entit

Updated on:January 26,2024